You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

22-223

Showing 1 - 25 of 3,663
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Reducing Colonoscopies in Patients Without Significant Bowel

Recruiting
  • Colorectal Cancer
  • +3 more
  • FIT and VOC
  • Coventry, West Midlands, United Kingdom
  • +3 more
Jan 10, 2022

Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

Not yet recruiting
  • Influenza, Human
  • +4 more
  • aH5N8c on Day 1
  • +4 more
  • Cullman, Alabama
  • +8 more
May 15, 2023

Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 31, 2022

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Anchorage, Alaska
  • +163 more
Jan 18, 2023

Effects of Immunotherapy Trial in Zagazig (Sublingual immunotherapy)

Completed
  • Effects of Immunotherapy
  • Sublingual immunotherapy
  • Zagazig, Egypt
    Fatma Zohry Kamel Khater
Dec 18, 2022

Prostate Cancer Patients Trial in Philadelphia (11C-Acetate)

Completed
  • Prostate Cancer Patients
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 12, 2022

Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

Completed
Has Results
  • Multiple Myeloma
  • +6 more
  • Los Angeles, California
  • +15 more
Dec 9, 2022

Periodontal Therapy, miRNA-223, Periodontitis Trial in Istanbul (experimental-periodontitis-mirna-223-gingival tissue-saliva

Recruiting
  • Periodontal Therapy
  • +3 more
  • experimental-periodontitis-mirna-223-gingival tissue-saliva samples
  • control-clinical healthy mirna-223-gingival tissue-saliva samples
  • Istanbul, İstanbul, Zeytinburnu, Turkey
    Biruni Üniversitesi
May 17, 2022

Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)

Completed
Has Results
  • Breast Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Yuma, Arizona
  • +93 more
Nov 4, 2022

Tuberculosis, Tuberculosis, Pulmonary Trial in Fair Lawn (1800 mg TBI-223, 2400mg TBI-223, 3000mg TBI-223)

Completed
  • Tuberculosis
  • Tuberculosis, Pulmonary
  • 1800 mg TBI-223
  • +3 more
  • Fair Lawn, New Jersey
    TKL Research, Inc.
Apr 13, 2022

COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Tozorakimab
  • Placebo
  • Lincoln, California
  • +113 more
Feb 15, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Nivolumab)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Apr 21, 2022

A Study of Cognitive Health in Survivors of Prostate Cancer

Recruiting
  • Prostate Cancer
  • Survivorship
  • PROMIS-SF v2.0 -Cognitive Function 8a
  • Basking Ridge, New Jersey
  • +6 more
Sep 13, 2022

Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)

Completed
Has Results
  • Prostate Cancer
  • Los Angeles, California
  • +4 more
Jun 15, 2021

Learn More About How Radium-223 is Being Used With Other

Active, not recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium 223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Denmark
  • +2 more
Jan 16, 2023

COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Mobile, Alabama
  • +199 more
Aug 10, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

Hypertension,Essential Trial in Seoul (AD-223A, AD-223B, AD-223C)

Not yet recruiting
  • Hypertension,Essential
  • Seoul, Korea, Republic of
    Hanyang University Hospital
Sep 19, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +26 more
Jan 25, 2023

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers

Completed
  • Periodontitis, Adult
  • miRNA-223 & -214 detection
  • Fayoum, Egypt
    faculty of dentistry, Fayoum university
Sep 26, 2023

Health-related Quality of Life, Psychological Distress and

Completed
  • Castrate Resistant Prostate Cancer
  • Bone Metastases
  • 's-Hertogenbosch, Netherlands
  • +10 more
Jul 29, 2021

Treatment Satisfaction With Ra-223 in Japan

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Japan
    Many Locations
Jan 12, 2023

How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

Recruiting
  • Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Taiwan
    Many locations
Aug 19, 2022